Prothena | PRTA - الأصول





الأصول تغيير تاريخ
Acadia Pharmaceuticals USD 1.61B 41.04M 2026-03
Agios Pharmaceuticals USD 1.11B 76.57M 2026-06
Akebia Therapeutics USD 362.52M 14.04M 2026-03
ALKERMES USD 4.39B 135.05M 2026-06
Alnylam Pharmaceuticals USD 5.56B 429.22M 2026-06
Amgen USD 92.5B 1.92B 2026-03
Biogen USD 32.09B 2.6B 2026-06
BioMarin Pharmaceutical USD 8.59B 996.99M 2026-03
Exelixis USD 2.59B 250.83M 2026-03
Immunic USD 189.74M 165.69M 2026-03
Incyte USD 7.87B 533.53M 2026-06
Ionis Pharmaceuticals USD 2.99B 455.5M 2026-06
MacroGenics USD 217.87M 38.97M 2026-03
Nektar Therapeutics USD 280.41M 20.94M 2025-12
Neurocrine Biosciences USD 5.36B 452.9M 2026-06
Prothena USD 349.89M 23.09M 2026-03
Regeneron Pharmaceuticals USD 41.73B 861.8M 2026-06
Ultragenyx Pharmaceutical USD 1.3B 236M 2026-03
Vertex Pharmaceuticals USD 26.48B 841.4M 2026-03